The mRNA-1273 Vaccine Induces Cross-Variant Antibody Responses to SARS-CoV-2 With Distinct Profiles in Individuals With or Without Pre-Existing Immunity

mRNA-based vaccines effectively induce protective neutralizing antibodies against SARS-CoV-2, the etiological agent of COVID-19. Yet, the kinetics and compositional patterns of vaccine-induced antibody responses to the original strain and emerging variants of concern remain largely unknown. Here we...

Descripción completa

Detalles Bibliográficos
Autores principales: Tejedor Vaquero, Sonia, de Campos-Mata, Leire, Ramada, José María, Díaz, Pilar, Navarro-Barriuso, Juan, Ribas-Llaurado, Clara, Rodrigo Melero, Natalia, Carolis, Carlo, Cerutti, Andrea, Gimeno, Ramon, Magri, Giuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446508/
https://www.ncbi.nlm.nih.gov/pubmed/34539673
http://dx.doi.org/10.3389/fimmu.2021.737083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446508/
https://www.ncbi.nlm.nih.gov/pubmed/34539673
http://dx.doi.org/10.3389/fimmu.2021.737083

Ejemplares similares